Medtronic plc (MDT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Medtronic, plc (Medtronic), formerly Medtronic, Inc., is a medical technology company. It develops, manufactures and markets a wide range of medical devices, therapies and services used in the treatment of chronic conditions such as heart disease, spinal conditions, neurological disorders, vascular disease and diabetes. Its major products include aortic and peripheral vascular products, cardiac rhythm and heart failure products, coronary and structural heart products, advanced surgical technologies and general surgical products, medical supplies, respiratory and monitoring solutions, and venous solutions, diabetes services and solutions, intensive insulin management solutions, non-intensive diabetes therapies, neuromodulation and neurovascular devices, orthopedic and spine products and surgical technologies. The company sells its products through direct sales force in the US and a combination of direct sales representatives and independent distributors in markets outside the US. The company serves physicians, patients and clinicians in Asia Pacific, Europe, the Americas, the Middle East and Africa. Medtronic is headquartered in Dublin, Ireland.
Medtronic plc Key Recent Developments
Jun 12, 2016: IBM Watson Health Showcases Progress Tackling Diabetes at American Diabetes Association’s 76th Scientific Sessions
Jun 10, 2016: Medtronic Converts 125 Million Patient Days of Data Into Personalized Insights That Improve Diabetes Management
Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day
May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
May 31, 2016: Medtronic Strengthens Commitment to Asia Pacific
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
'
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Section 1 - About the Company 7
Medtronic plc - Key Facts 7
Medtronic plc - Key Employees 8
Medtronic plc - Key Employee Biographies 10
Medtronic plc - Major Products and Services 11
Medtronic plc - Medical Equipment Pipeline Products Data 14
Medtronic plc Pipeline Products by Equipment Type 14
Medtronic plc Pipeline Products by Development Stage 21
Medtronic plc - Pharmaceutical Pipeline Products Data 25
Medtronic plc, Pipeline Products by Therapy Area 25
Medtronic plc, Pipeline Products by Development Phase 26
Medtronic plc - History 27
Medtronic plc - Company Statement 53
Medtronic plc - Locations And Subsidiaries 57
Head Office 57
Other Locations & Subsidiaries 57
Section 2 – Company Analysis 69
Medtronic plc - Business Description 69
Business Description - Cardiac and Vascular Group 69
Cardiac and Vascular Group - Overview 69
Cardiac and Vascular Group - Financials 70
Cardiac and Vascular Group - Market View 70
Business Description - Diabetes Group 70
Diabetes Group - Overview 70
Diabetes Group - Financials 70
Diabetes Group - Market View 70
Business Description - Minimally Invasive Technologies Group 70
Minimally Invasive Technologies Group - Overview 70
Minimally Invasive Technologies Group - Financials 71
Business Description - Restorative Therapies Group 71
Restorative Therapies Group - Overview 71
Restorative Therapies Group - Financials 71
Restorative Therapies Group - Market View 71
Medtronic plc - Corporate Strategy 72
Medtronic plc - SWOT Analysis 73
SWOT Analysis - Overview 73
Medtronic plc - Strengths 73
Strength - Cardiac and Vascular Group 73
Strength - Innovation and Research and Development 73
Strength - Business Combination 73
Strength - Improved Performance of Restorative Therapies Group 74
Medtronic plc - Weaknesses 75
Weakness - Patent Infringement Concerns 75
Weakness - Product Safety Concerns 75
Weakness - Declining Performance of Spine Division 75
Medtronic plc - Opportunities 76
Opportunity - Growing Diabetes Care Devices Market 76
Opportunity - Product Innovation 76
Opportunity - Inorganic Growth Initiatives 76
Opportunity - Strong Growth Potential: Minimally Invasive Technologies Group 77
Opportunity - Strategic Partnerships 77
Medtronic plc - Threats 78
Threat - Stiff Competition 78
Threat - Cost Containment Measures 78
Threat - Integration of Acquisitions 78
Threat - Stringent Regulations 78
Medtronic plc - Key Competitors 79
Section 3 – Company Financial Ratios 80
Financial Ratios - Capital Market Ratios 80
Financial Ratios - Annual Ratios 81
Performance Chart 83
Financial Performance 83
Financial Ratios - Interim Ratios 84
Financial Ratios - Ratio Charts 85
Section 4 – Company’s Lifesciences Financial Deals and Alliances 86
Medtronic plc, Medical Equipment, Deals By Year, 2010 to YTD 2016 86
Medtronic plc, Medical Equipment, Deals By Type, 2010 to YTD 2016 87
Medtronic plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 88
Medtronic plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 89
Medtronic plc, Recent Deals Summary 90
Section 5 – Company’s Recent Developments 91
Jun 12, 2016: IBM Watson Health Showcases Progress Tackling Diabetes at American Diabetes Association’s 76th Scientific Sessions 91
Jun 10, 2016: Medtronic Converts 125 Million Patient Days of Data Into Personalized Insights That Improve Diabetes Management 93
Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 95
May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 96
May 31, 2016: Medtronic Strengthens Commitment to Asia Pacific 99
May 19, 2016: Medtronic Announces U.S. Launch of Spine Essentials Demonstrating Its Commitment to Create Value in Healthcare 100
May 04, 2016: Medtronic Welcomes Karen L. Parkhill as Its New Chief Financial Officer 101
Apr 20, 2016: Medtronic Announces Worldwide Voluntary Recall for Battery Pack in Covidien Oridion Labeled Capnostream20 and Capnostream20p Patient Monitors 102
Apr 18, 2016: Material in Medtronic Leads Inducted into Space Technology Hall of Fame 103
Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations 104
Section 6 – Appendix 105
Methodology 105
Ratio Definitions 105
About GlobalData 109
Contact Us 109
Disclaimer 109
List of Tables
Medtronic plc, Key Facts 7
Medtronic plc, Key Employees 8
Medtronic plc, Key Employee Biographies 10
Medtronic plc, Major Products and Services 11
Medtronic plc Number of Pipeline Products by Equipment Type 14
Medtronic plc Pipeline Products by Equipment Type 15
Medtronic plc Number of Pipeline Products by Development Stage 21
Medtronic plc Pipeline Products by Development Stage 22
Medtronic plc, Number of Pipeline Products by Therapy Area 25
Medtronic plc, Number of Pipeline Products by Development Stage 26
Medtronic plc, History 27
Medtronic plc, Other Locations 57
Medtronic plc, Subsidiaries 57
Medtronic plc, Key Competitors 79
Medtronic plc, Ratios based on current share price 80
Medtronic plc, Annual Ratios 81
Medtronic plc, Interim Ratios 84
Medtronic plc, Medical Equipment, Deals By Year, 2010 to YTD 2016 86
Medtronic plc, Medical Equipment, Deals By Type, 2010 to YTD 2016 87
Medtronic plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 88
Medtronic plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 89
Medtronic plc, Recent Deals Summary 90
Currency Codes 105
Capital Market Ratios 105
Equity Ratios 106
Profitability Ratios 106
Cost Ratios 107
Liquidity Ratios 107
Leverage Ratios 108
Efficiency Ratios 108
List of Figures
Medtronic plc Pipeline Products by Equipment Type 14
Medtronic plc Pipeline Products by Development Stage 21
Medtronic plc, Pipeline Products by Therapy Area 25
Medtronic plc, Pipeline Products by Development Phase 26
Medtronic plc, Performance Chart (2011 - 2015) 83
Medtronic plc, Ratio Charts 85
Medtronic plc, Medical Equipment, Deals By Year, 2010 to YTD 2016 86
Medtronic plc, Medical Equipment, Deals by Type, 2010 to YTD 2016 87
Medtronic plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 88
Medtronic plc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 89
